Clinical & Pharmacogenomics
Clinical pharmacology is the science of drugs and their clinical use also it is underpinned by the main science of pharmacology with an added focus on the application of pharmacological principles and quantitative methods in the real world, therefore clinical pharmacology is not specific to medicine. The purpose of pharmacogenitics analyses how the genetic makeup of an individual effects on human response to drugs. Pharmacogenomics aims to improve rational means to optimize drug therapy, with regard to the patient’s genotype to ensure maximum efficiency with minimal adverse effects.
- Cardiovascular Diseases and Drugs
- Personalized Vaccines and Immunity
- Drug Labeling and Controversies
- Ethical, Legal and Social Implications
- Small Molecules for Future Medicine
- Heredatory and Neurodegenerative Disorders
- Cancer Chemotherapy and personalized medicine
Related Conference of Clinical & Pharmacogenomics
October 27-28, 2025
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Madrid, Spain
November 17-18, 2025
18th International Conference on Human Genomics and Genomic Medicine
Paris, France
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Clinical & Pharmacogenomics Conference Speakers
Recommended Sessions
- Animal cells & Microbial Interactions
- Calcium and Cell Function
- Cancer Genomics
- Cell and Immunology
- Cell Cycle and Cytogenetics
- Cell Physiology and Biochemistry
- Cellular Metabolism & Signalling
- Clinical & Pharmacogenomics
- Computational Biology & Next generation sequencing
- Data integration, Modelling and prediction
- Epigenetics & Metagenomics
- Gene expression & Genetic Changes
- Genomic Medicine
- Human Genomics
- Membrane Processes
- Microbial Glycobiology & Genomics
- Molecular Biology & Transcriptomics
- Molecular Biology Techniques
- Molecular Cell Biology
- Plant Biology & Genomics
- Population & Evolutionary Genomics
- Proteomics and Transcriptomics
- Recombinant DNA Technology
- Single Cell biology
- Stem Cells & Tissue Engineering
- Structural & Functional Genomics
- Structural Biology
- Yeast artificial Chromosome
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)